Detalhe da pesquisa
1.
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures.
Lancet Oncol
; 24(6): e270-e283, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269858
2.
Productivity losses in patients with newly diagnosed multiple myeloma following stem cell transplantation and the impact of maintenance therapy.
Eur J Haematol
; 103(4): 393-401, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31325331
3.
Individual Trade-Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma.
Oncologist
; 23(1): 44-51, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29079638
4.
Regenerative medicine: Stroke survivor and carer views and motivations towards a proposed stem cell clinical trial using placebo neurosurgery.
Health Expect
; 21(1): 367-378, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29024214
5.
What matters most to patients with multiple myeloma? A Pan-European patient preference study.
Front Oncol
; 12: 1027353, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36523996
6.
Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study.
Front Med (Lausanne)
; 8: 686165, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34295912
7.
Myeloma Patient Value Mapping: A Discrete Choice Experiment on Myeloma Treatment Preferences in the UK.
Patient Prefer Adherence
; 14: 1283-1293, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32801659
8.
What do families, staff, and stakeholders think about children's dream fulfilment?
Issues Compr Pediatr Nurs
; 37(4): 203-11, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25180687